Does CHA2DS2-VASc Score Predict MACE in Patients Undergoing Isolated Coronary Artery Bypass Grafting Surgery?

Muhsin Kalyoncuoglu1, Semi Ozturk1, Mazlum Sahin2

  • 1Haseki Training and Research Hospital Department of Cardiology Istanbul Turkey Department of Cardiology, Haseki Training and Research Hospital, Istanbul, Turkey.

Insights

The CHA2DS2-VASc score can predict major adverse cardiac events (MACE) in patients undergoing isolated coronary artery bypass grafting (CABG). This score offers valuable prognostic insight for CABG patients, aiding in risk stratification and clinical decision-making.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Clinical Risk Stratification

Background:

  • Coronary artery bypass grafting (CABG) is a common procedure for severe coronary artery disease.
  • Accurate prediction of major adverse cardiac events (MACE) post-CABG is crucial for patient management.
  • The prognostic utility of the CHA2DS2-VASc score in isolated CABG patients remains to be fully elucidated.

Purpose of the Study:

  • To evaluate the prognostic value of the CHA2DS2-VASc score in predicting MACE after isolated CABG surgery.
  • To compare the predictive accuracy of CHA2DS2-VASc score with other established risk scores.

Main Methods:

  • Retrospective review of 464 patients undergoing elective isolated CABG.
  • Patients were stratified into low (<2) and high (≥2) CHA2DS2-VASc score groups.
  • Univariate logistic regression and receiver-operating characteristic (ROC) curve analysis were used to assess MACE prediction.

Main Results:

  • Higher CHA2DS2-VASc scores were associated with increased prevalence of comorbidities like hypertension and diabetes.
  • Patients with high CHA2DS2-VASc scores exhibited significantly higher rates of in-hospital mortality and MACE.
  • CHA2DS2-VASc score demonstrated strong specificity (84.1%) in predicting MACE, with comparable accuracy to SYNTAX II-CABG score.

Conclusions:

  • The CHA2DS2-VASc score is a valuable and specific predictor of MACE in patients undergoing isolated CABG.
  • This score can aid clinicians in risk stratification and optimizing perioperative management for CABG patients.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
934
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
400
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
230
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
351
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
615
Introduction to z Scores01:06

Introduction to z Scores

A z score (or standardized value) is measured in units of the standard deviation. It tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a zero z score. It is important to note that the mean of the z scores is zero, and the standard deviation is one.
z scores...
11.0K